Moderna, Inc. (BMV:MRNA)

Mexico flag Mexico · Delayed Price · Currency is MXN
515.00
-40.00 (-7.21%)
At close: Aug 1, 2025, 2:00 PM CST
-7.21%
Market Cap202.67B
Revenue (ttm)58.05B
Net Income (ttm)-54.75B
Shares Outn/a
EPS (ttm)-141.95
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,053
Average Volume1,095
Open530.99
Previous Close555.00
Day's Range506.00 - 530.99
52-Week Range454.50 - 1,909.99
Betan/a
RSI38.79
Earnings DateJul 31, 2025

About MorphoSys AG

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Employees 5,800
Stock Exchange Mexican Stock Exchange
Ticker Symbol MRNA
Full Company Profile

Financial Performance

In 2024, Moderna's revenue was $3.24 billion, a decrease of -52.75% compared to the previous year's $6.85 billion. Losses were -$3.56 billion, -24.46% less than in 2023.

Financial Statements

News

There is no news available yet.